Article Versions Notes

Kawasuji H, Tsuji Y, Ogami C, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Fukui Y, Sakamaki I, et al. Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients. Antibiotics. 2021; 10(5):496. https://doi.org/10.3390/antibiotics10050496

Kawasuji, Hitoshi, Yasuhiro Tsuji, Chika Ogami, Makito Kaneda, Yushi Murai, Kou Kimoto, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, and et al. 2021. "Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients" Antibiotics 10, no. 5: 496. https://doi.org/10.3390/antibiotics10050496

Kawasuji, H., Tsuji, Y., Ogami, C., Kaneda, M., Murai, Y., Kimoto, K., Ueno, A., Miyajima, Y., Fukui, Y., Sakamaki, I., & Yamamoto, Y. (2021). Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients. Antibiotics, 10(5), 496. https://doi.org/10.3390/antibiotics10050496